Midgard Science

Labs / ADME, DMPK & toxicology

B

BIMINI

Leiden, Netherlands · biminibiotech.nl

BIMINI Biotech is a preclinical-stage biotechnology company based in Leiden, the Netherlands. It develops first-in-class small molecule therapeutics by modulating WASp for oncology and autoimmune disease, including acute myeloid leukemia and rheumatoid arthritis.

They take quote requests by email.

What they offer

  • WASp activation programme

    Develops small molecules that increase WASp activity in selected cancers, including hematologic cancer programmes.

  • WASp inhibition programme

    Develops small molecules that reduce WASp function in autoimmune disease by increasing WASp degradation.

  • Hit-to-lead and lead optimisation

    Advances discovered compounds through potency and pharmacokinetic optimisation while maintaining activity.

  • Preclinical development

    Generates in vitro and in vivo proof-of-concept data to support therapeutic programmes.

  • Partnering and research collaboration

    Engages with academic, clinical, and industry partners for research collaborations and partnering discussions.

What they work on

Modalities
Small molecule
Species and models
hematologic cancer models, leukemia models, lymphoma models, collagen-induced arthritis model
Assays and studies
phenotypic screen, target identification, kinase profiling, target engagement, in vitro assays, in vivo proof of concept
Instruments and platforms
AI, cheminformatics
Therapeutic areas
oncology, autoimmune disease, acute myeloid leukemia, rheumatoid arthritis
Sites
Leiden, The Netherlands
Team
4+ team members
Serves
worldwide
Address
Galileiweg 8 2333 BD Leiden The Netherlands
Founded
2019

Public records

Ownership
BIMINI GROUP LTD · VG GLEIF

Similar labs. Aurigene Pharmaceutical Services, EyeCRO, MedChem Partners, Medibiofarma

Found in a contract services directory. Listing built from biminibiotech.nl. Work here? Claim this listing.

BIMINI · Midgard Science